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Abstract
Background: During implantation of a DDD pacemaker the following difficulties may be
encountered: venous anomalies (the absence of vessels of adequate calibre or difficulty in
subclavian vein puncture), arrhythmias during implantation (episodes of atrial flutter/fibril-
lation while the atrial leads are being positioned), lack of mechanical stability of the electrode
in the heart chamber and inability to achieve an acceptable pacing and sensing threshold
during implantation. The purpose of the study was to analyse retrospectively the reasons for
DDD pacemaker failure in patients operated on between 1993 and 2005.
Methods: We reviewed retrospectively all implantation data from 1988 to 2005 to identify
patients with primary failure of DDD pacemaker implantation. Further analysis included
patients who had received a DDD pacemaker between 1993 and 2005, when this type of
pacemaker made up between 9 and 40% of all pacemaker implantations. We implanted 7469
pacemakers, including 1958 (26.2%) dual-chamber pacemakers, in 783 patients with atriov-
entricular block (AVB), 392 with sick sinus syndrome (SSS), 450 with AVB – SSS and
333 with tachy-brady syndrome (TBS). The mean age of the patients was 65.5–17.3 years.
DDD pacing was unsuccessful in 108 (1.4%) patients, including 32 with AVB, 22 with SSS,
16 with SSS – AVB and 38 with TBS. The mean age of these patients was 78.5 – 19.4 years.
Results: The reasons for failed implantation were venous anomalies in 12%, an arrhythmia
episode in 27.8%, a high pacing threshold in the atrium in 17.6%, low atrial potential ampli-
tude in 25.9% and lack of mechanical stability of the electrode in 16.7% of patients.
The difficulties were encountered in elderly patients (p < 0.01), most frequently in patients
with SSS and TBS (71). Between 2004 and 2005 venous anomalies and a high pacing
threshold were the main causes of failure.
Conclusions: Currently the main difficulties encountered during pacemaker implantation
are venous anomalies and a high pacing threshold. Arrhythmia episodes, low atrial potential
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amplitude and lack of mechanical stability are of minor importance. Elderly patients with sick sinus
syndrome and tachy-brady syndrome have the highest failure rate. (Cardiol J 2007; 14: 155159)
Key words: arrhythmia episode, high pacing threshold, low atrial potential
amplitude, lack of mechanical stability, venous anomalies, DDD pacing
Introduction
In most cases permanent pacing is performed
with an endocavitary electrode. The electrodes are
inserted via the veins of the upper thorax and neck
[16] and, exceptionally, via the femoral vein (in
patients with superior vena cava syndrome) [7].
Exposure of the cephalic vein in the brachiot-
horacic groove is regarded as equivalent to subcla-
vian venipuncture technique [25]. When these two
main access sites are not available, it is recommend-
ed to use the veins lying between the pectoral mus-
cles or superficial jugular veins, side branches of the
internal jugular vein (the inferior thyroid vein or
transverse vein of the neck), the internal jugular
vein itself and, finally, venipuncture or exposure of
the internal jugular vein [7].
Implantation of a dual-chamber pacemaker in-
volves placement of a ventricular electrode followed
by an atrial electrode inserted via the same or an-
other vein. Appropriate fixation of the atrial elec-
trode (similar to the ventricular electrode) is con-
figured by a slight elevation of up to 0.2 mV of the
AV segment in the endocardial lead. Where there
is difficulty in placing atrial (ventricular) electrodes,
it is preferable to use active fixation electrodes [2].
To sum up, during implantation of a DDD pace-
maker the following difficulties may be encoun-
tered:
 venous anomalies (absence of vessels of ade-
quate calibre or difficulty in subclavian vein
puncture);
 arrhythmias during implantation (episodes of
atrial flutter/fibrillation while the atrial leads
are being positioned);
 lack of mechanical stability of the electrode in
the heart chamber;
 inability to achieve an acceptable pacing and
sensing threshold during implantation (mainly
in the atrium).
These difficulties may be the reason for chang-
ing the primary decision regarding DDD pacemak-
er implantation. The purpose of the study was to
analyse retrospectively the reasons for DDD pace-
maker failures in patients operated on between 1993
and 2005. A review of the available literature shows
that there are no publications dealing extensively
with this problem. There are, however, separate
reports of electrode insertion during atrial flutter/
/fibrillation and at low atrial potential amplitude.
Methods
According to the guidelines for electrotherapy
of the heart [1], apart from achieving appropriate
electrode placement, it is necessary to optimise
sensing and pacing parameters and to achieve at
least the threshold values of:
 ventricular potential amplitude > 4 mV;
 rate of rise of ventricular potential > 0.5 V/s;
 atrial potential amplitude > 2 mV;
 rate of rise of atrial potential > 0.2 V/s;
 pacing threshold < 1.0 V/0.5 ms [1].
Not all episodes of supraventricular arrhythmia
were the cause of a change in pacing mode. Cardiac
arrhythmia that did not resolve spontaneously and
was resistant to anti-arrhythmic drugs forced us to
abandon implantation of a DDD pacemaker. Cardio-
version was not performed during the procedure.
Mechanical stability of the electrode was con-
firmed during the Valsalva manoeuvre and while the
patient was coughing. The myocardial pacing
threshold was checked during these manoeuvres.
In patients with venous anomalies (cephalic
vein, other tributaries of the subclavian vein and
difficulty in puncture of the latter) we made an at-
tempt to implant the pacemaker on the contralat-
eral side. In most cases the procedure was success-
ful. The implantation procedure was always per-
formed by the most experienced operator. Contrast
medium was injected to a peripheral vein to visual-
ise abnormalities. Occlusion of the subclavian vein
and absence of a tributary of adequate calibre were
the most frequent anomalies.
Passive fixation electrodes were applied and in
the event of mechanical instability the screw-in type
was used. Atrial electrodes were placed in the right
atrial appendage, whereas, until 2004 ventricular
electrodes were placed at the right ventricular apex.
A pacing threshold in the atrium above 2 V was re-
garded as unacceptably high.
We retrospectively reviewed all implantation
data from 1988 to 2005 to identify patients with
primary failure of DDD pacemaker implantation.
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These patients finally received a VVI pacemaker.
As the number of DDD pacemakers implanted be-
tween 1988 and 1992 was too small (below 8%),
further analysis included patients who had received
a DDD pacemaker between 1993 and 2005, when
this type of pacemaker made up between 9 and 40%
of all pacemaker implantations. At this time we
implanted 7469 pacemakers, including 1958 (26.2%)
dual-chamber pacemakers, in 783 patients with atri-
oventricular block (AVB), 392 with sick sinus syn-
drome (SSS), 450 with AVB – SSS and 333 with
tachy-brady syndrome (TBS). The mean age of the
patients was 65.5 – 17.3 years. DDD pacing was
unsuccessful in 108 (1.4%) patients, including
32 with AVB, 22 with SSS, 16 with SSS–AVB and
38 with TBS (Table 1). The mean age of the patients
at the time of implantation was 78.5–19.4 years
(1694) and 3361 (45%) were men. DDD pacing was
unsuccessful in 108 (1.4%) patients, including
Table 1. The number of pacemaker implanta-
tions in consecutive years.
Years No. of all implantation/
/no. of DDD pacemakers
1993 465/43 (9%)
1994 469/88 (18%)
1995 465/81 (17%)
1996 506/103 (20%)
1997 524/132 (25%)
1998 500/131 (26%)
1999 479/135 (28%)
2000 532/103 (19%)
2001 587/131 (22%)
2002 707/174 (24%)
2003 806/271 (33%)
2004 646/264 (40%)
2005 783/302 (38%)
Table 2. Reasons for failure of DDD pacemaker implantation in consecutive years.
Reasons for failure of DDD 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
pacemaker implantation
Venous anomalies 13 (12%) 0 1 2 1 0 1 1 2 1 3 0 0 1
Episode of atrial flutter 1 1 3 5 3 5 4 5 1 0 2  0 0
or fibrillation 30 (27.8%)
High pacing threshold 19 (17.6%) 2 2 1 0 0 1 0 2 2 0 1 5 3
Low atrial potential amplitude 4 2 11 2 2 2 1 1 2 1 0 0  0
28 (25.9%)
Lack of mechanical stability 3 4 5 2 1 1 1 1 0 0 0 0  0
18 (16.7%)
32 with AVB, 22 with SSS, 16 with SSS – AVB and
38 with TBS. The mean age of these patients was
78.5 – 19.4 years and there were 46 men (43%).
Statistical analysis
Data are expressed as mean – 1 standard de-
viation and as a percentage. Students t-test was
used for analysis. A p value below 0.05 was consid-
ered significant.
Results
The reasons for abandoning implantation of DDD
pacemakers were venous anomalies in 13 (12%), an
episode of atrial flutter/fibrillation during the proce-
dure in 30 (27.8%), a high pacing threshold in the atri-
um in 19 (17.6%), low atrial potential amplitude in
28 (25.9%) and lack of mechanical stability of the elec-
trode in 18 (16.7%) patients (Table 2).
We were most frequently forced to abandon
the implantation of a DDD pacemaker in SSS and TBS
(71 cases) as a result of an arrhythmia episode,
low amplitude and lack of mechanical stability
(Table 3).
Between 1993 and 2003 excessively low atri-
al potential amplitude and arrhythmia episodes
(atrial flutter/fibrillation) during the procedure
were the main causes of failure. Of note is the
decrease in the rate of unsuccessful insertion of
atrial electrodes with increasing experience and
technological progress in electrodes and pace-
makers and between 2004 and 2005 the absence
of failure as a result of arrhythmia episodes, low
atrial potential amplitude and inappropriate me-
chanical stability of the electrode. Only single
cases of venous anomaly and a high pacing thresh-
old were encountered. Patients in whom the pri-
mary procedure was abandoned were older than
those with successful implantation of a DDD pace-
maker (p < 0.01).
158
Cardiology Journal 2007, Vol. 14, No. 2
www.cardiologyjournal.org
Unfortunately it is not possible to provide fluor-
oscopy times during the implantation of DDD pace-
makers in consecutive years. It is now 10 minutes
on average; prior to 1998 it was much longer, at
about 25 minutes.
Discussion
On 4 October 1984 the first dual-chamber pace-
maker (multiprogrammable Medtronic Symbios
7006) was implanted in a 57-year-od man with sec-
ond-degree AVB and transiently third-degree AVB
with Morgani-Adams-Stokes syndrome. We used
the original bipolar electrodes (a straight ventricu-
lar electrode and a J-shaped atrial electrode). The
ventricular electrode was fixed as usual at the right
ventricular apex. The atrial electrode was inserted
via venipuncture of the subclavian vein under fluor-
oscopic control and fixed in the right atrial append-
age. By the end of 1985, probably for financial rea-
sons, only three more dual-chamber pacemakers
had been implanted [8]. In 1993 the number of im-
planted DDD pacemakers began to increase stead-
ily (> 9%) and as a result later analysis included
patients who had received a DDD pacemaker be-
tween 1993 and 2005. A total of 7469 pacemakers
were implanted, of which 26.2% were dual-cham-
ber pacemakers. In 2006 dual-chamber pacemakers
made up 49% of all implantations.
In 108 patients selected for dual-chamber pac-
ing the procedure was abandoned and VVI pacing
was used. These patients were older (78.5 years),
probably with greater myocardial injury and 55% of
them had SSS and TBS. The reasons for failure were
low atrial potential amplitude (< 2 mV), an arrhyth-
mia episode (atrial flutter/fibrillation) during manip-
ulation of the atrial electrode, lack of mechanical
stability and a high atrial pacing threshold (> 2 V).
The first three causes were most frequently en-
countered in patients with SSS and TBS.
The rate of failure decreased with increasing
experience and progress in pacemaker technology
[911]. In 1997 the introduction of bipolar active
fixation electrodes (screw-in endocavitary elec-
trodes) and multiprogrammable pacemakers with
special anti-tachycardia features and atrial sensitiv-
ity programmed to 0.1 mV allowed for better me-
chanical stability of the electrode and implantation
at low atrial potential amplitude (< 2 mV). Further-
more, atrial flutter/fibrillation during insertion of the
atrial electrodes is no longer a significant problem.
According to Kindermann et al. [12], in the event
of unexpected arrhythmia atrial electrodes should
be placed in locations with potential amplitudes
above 1.0 mV [1315]. This is a useful approach to
achieving sufficient atrial sensing after restoration
of sinus rhythm and the only remaining problems
between 2004 and 2005 were venous anomalies and
a high pacing threshold.
The high rate of arrhythmias (27.8%) during the
procedure was found mainly in patients with the TBS.
Several investigators [12, 13, 16] report rates rang-
ing from 1 to 5.5%, but mainly in patients with
pure SSS, in whom, under normal conditions, the
rate of arrhythmias is much lower. Anomalies of the
cephalic vein (absent vein or hypoplasia) occur in
about 10% of patients undergoing pacemaker im-
plantation (about 0.6% in the present study) and,
according to Wiegand et al. [17], in about 2% of pa-
tients undergoing pacemaker implantation it was
impossible to achieve correct electrical parameters
(in 2.4% in the present study).
Despite the limitations of the present study
related to its retrospective character some impor-
tant conclusions can be drawn.
Conclusions
1. Currently the main reasons for abandoning im-
plantation of dual-chamber pacemakers are
Table 3. Reasons for failure of DDD pacemaker implantation according to indication. Patients with indi-
cations to pacemaker implantation (N = 108).
Reasons for failure of DDD AVB SSS SSS + AVB TBS
pacemaker implantation  (n = 32)  (n = 22) (n = 16) (n = 38)
Venous anomalies  13 4 3 4 2
Episode of atrial flutter or fibrillation  30 2 7 5 16
High pacing threshold  19 5 4 5 5
Low atrial potential amplitude  28 4 8 4 12
Lack of mechanical stability  18 1 5 3 9
AVB  atrioventricular block, SSS  sick sinus syndrome, SSS + AVB  double node disease, TBS  tachy-brady syndrome
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venous anomalies and a high pacing threshold
(> 2 V). Low atrial potential amplitude, ar-
rhythmia episodes and lack of mechanical sta-
bility are of minor importance.
2. Elderly patients with sick sinus syndrome and
tachy-brady syndrome have the highest failure rate.
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